Each cell in your body relies on precise communication with other cells to function properly. At the center of this process ...
Urcosmid is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune ...
23h
GlobalData on MSNBoehringer Ingelheim and Salipro enter drug discovery partnershipThe partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.
Myrobalan to receive over $850,000 in funding to advance the development of its GPR17 antagonist for progressive MS from the ...
This study makes the fundamental discovery of the first natural animal rhodopsin that uses a chloride ion instead of an amino acid side chain as a counterion. Using a combination of biochemical and ...
Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license agreement with ...
Salipro Biotech has signed a research and license agreement with Boehringer Ingelheim to accelerate the development of ...
Privately-held Swedish firm Salipro Biotech AB, a specialist in the stabilization of challenging drug targets, today ...
Researchers at Monash University have uncovered how the gut—and the food we eat—affects high blood pressure. Their discovery ...
Sotio Biotech is pushing deeper into bispecific antibody-drug conjugates (ADC), taking up its option to use Synaffix’s ...
In February, three insiders bought a combined total of $6.61 million in Septerna shares at an average price of $5.79 per ...
Now, in a collaborative study, Merchier and De Strooper's research groups have identified the orphan G protein-coupled receptor GPR3 as a potential new therapeutic target for Alzheimer's disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results